14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 ALNY stock ended at $154.33. This is 2.06% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 2.79% from a day low at $150.83 to a day high of $155.04.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Feb 27, 2023 $191.85 $193.19 $187.52 $190.01 710 890
Feb 24, 2023 $191.77 $199.58 $188.68 $189.78 1 521 273
Feb 23, 2023 $198.00 $202.12 $192.54 $196.24 1 403 102
Feb 22, 2023 $199.02 $205.23 $197.61 $201.10 909 206
Feb 21, 2023 $216.83 $218.14 $199.02 $199.86 1 622 551
Feb 17, 2023 $220.39 $225.22 $218.21 $222.79 503 130
Feb 16, 2023 $220.73 $222.44 $218.74 $219.85 481 306
Feb 15, 2023 $223.01 $224.00 $219.61 $222.10 365 007
Feb 14, 2023 $221.33 $227.91 $221.11 $224.91 493 840
Feb 13, 2023 $215.56 $224.34 $213.97 $222.34 489 917
Feb 10, 2023 $216.06 $217.51 $212.71 $215.26 582 458
Feb 09, 2023 $219.31 $222.08 $214.87 $215.58 321 876
Feb 08, 2023 $220.82 $222.64 $216.43 $217.75 433 195
Feb 07, 2023 $223.73 $224.35 $214.86 $220.95 850 673
Feb 06, 2023 $230.74 $234.70 $224.02 $224.14 697 445
Feb 03, 2023 $228.38 $234.02 $227.63 $233.37 1 203 385
Feb 02, 2023 $225.60 $230.97 $224.00 $229.75 908 156
Feb 01, 2023 $228.15 $228.15 $220.07 $224.91 680 861
Jan 31, 2023 $228.87 $229.99 $224.67 $226.40 1 112 090
Jan 30, 2023 $229.81 $231.48 $224.25 $225.40 611 506
Jan 27, 2023 $231.59 $232.20 $225.52 $231.37 726 617
Jan 26, 2023 $232.23 $234.02 $228.77 $231.59 546 550
Jan 25, 2023 $226.70 $229.55 $225.02 $229.02 637 408
Jan 24, 2023 $229.42 $232.36 $227.79 $228.11 558 135
Jan 23, 2023 $228.85 $234.78 $227.11 $230.59 570 703
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT